Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06005987 · ClinicalTrials.gov registry record · NA
Mobile App Logging for Diabetes in Pregnancy
A NA study of Type 2 Diabetes and Gestational Diabetes Mellitus in Pregnancy, sponsored by Carolyn Zahler-Miller.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06005987: Recruiting NA study of Type 2 Diabetes and Gestational Diabetes Mellitus in Pregnancy, sponsored by Carolyn Zahler-Miller.
NCT06005987 is a NA study of Type 2 Diabetes and Gestational Diabetes Mellitus in Pregnancy that is actively recruiting participants, run by Carolyn Zahler-Miller. The registered enrollment target is 40 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06005987, a NA study of Type 2 Diabetes and Gestational Diabetes Mellitus in Pregnancy, is actively recruiting participants, sponsored by Carolyn Zahler-Miller.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Primary Outcome
percentage of actual blood glucose values logged compared to expected.
Conditions Studied
Interventions
- BEHAVIORAL OneTouch Reveal application
Study Locations (1)
Georgia
- Augusta University - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT06005987 shows while recruiting
NCT06005987 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which OneTouch Reveal application is the first listed.
NCT06005987 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06005987 about?
NCT06005987 is a clinical study titled "Mobile App Logging for Diabetes in Pregnancy". To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
What is the current status of trial NCT06005987?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-06-01. Estimated completion is 2027-01-01.
What conditions does trial NCT06005987 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Gestational Diabetes Mellitus in Pregnancy.
What interventions are being tested in trial NCT06005987?
The interventions under investigation include: OneTouch Reveal application (BEHAVIORAL).
Who is sponsoring clinical trial NCT06005987?
This trial is sponsored by Carolyn Zahler-Miller, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06005987 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06005987's enrollment target sits among peer trials
40 231st of 327 higher than 88 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI